Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Jassem%2C+J%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Jassem%2C+J%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2014
Mark Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
Bonnefoi, H. ; Litiere, S. ; Piccart, M. ; MacGrogan, G. ; Fumoleau, P. ; Brain, E. ; Petit, T. ; Rouanet, P. ; Jassem, J. and Moldovan, C. , et al. (2014) In Annals of Oncology 25(6). p.1128-1136
- Contribution to journal › Article
2006
Mark Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism
Szymanowska, A ; Jassem, E ; Dziadziuszko, R ; Borg, Åke ^LU ; Limon, J ; Kobierska-Gulida, G ; Rzyman, W and Jassem, J (2006) In Lung Cancer 52(1). p.9-14
- Contribution to journal › Article
Mark Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)
Beex, L. ; Rose, Carsten ^LU ; Mouridsen, H. ; Jassem, J. ; Nooij, M. ; Estape, J. ; Paridaens, R. ; Piccart, M. ; Gorlia, T. and Lardenoije, S. , et al. (2006) In European Journal of Cancer 42(18). p.3178-3185
- Contribution to journal › Article